Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

Por Brevet, Marie, Arcila, Maria, Ladanyi, Marc
Publicado em 2010

Detection of KRAS and BRAF Mutations in Colorectal Carcinoma: Roles for High-Sensitivity Locked Nucleic Acid-PCR Sequencing and Broad-Spectrum Mass Spectrometry Genotyping

Por Arcila, Maria, Lau, Christopher, Nafa, Khedoudja, Ladanyi, Marc
Publicado em 2011

Appendiceal Inversion: a Diagnostic and Therapeutic Dilemma

Por Johnson, Eric K., Arcila, Maria E., Steele, Scott R.
Publicado em 2009

MET-Dependent Solid Tumors: Molecular Diagnosis and Targeted Therapy

Por Guo, Robin, Luo, Jia, Chang, Jason, Rekhtman, Natasha, Arcila, Maria, Drilon, Alexander
Publicado no Nat Rev Clin Oncol (2020)

A case of acute myeloid leukemia with e6a2 BCR-ABL fusion transcript acquired after progressing from chronic myelomonocytic leukemia

Por Yao, Jinjuan, Douer, Dan, Wang, Lu, Arcila, Maria E., Nafa, Khedoudja, Chiu, April
Publicado no Leuk Res Rep (2017)

New Strategies in Overcoming Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Por Oxnard, Geoffrey R., Arcila, Maria E., Chmielecki, Juliann, Ladanyi, Marc, Miller, Vincent A., Pao, William
Publicado em 2011

Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profiles

Por Rekhtman, Natasha, Borsu, Laetitia, Reva, Boris, Arcila, Maria, Riely, Gregory J., Ladanyi, Marc, Drilon, Alexander
Publicado em 2014

Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers

Por Eng, Juliana, Hsu, Meier, Chaft, Jamie E., Kris, Mark G., Arcila, Maria E., Li, Bob T.
Publicado no Lung Cancer (2016)

Reduced H3K27me3 Expression in Merkel Cell Polyoma Virus-Positive Tumors

Por Busam, Klaus J, Pulitzer, Melissa P, Coit, Daniel C, Arcila, Maria, Leng, Danielle, Jungbluth, Achim A, Wiesner, Thomas
Publicado no Mod Pathol (2017)

JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation

Por Xiao, Wenbin, Rampal, Raajit, Zhang, Yanming, Cimera, Robert, Jungbluth, Achim A., Arcila, Maria, Roshal, Mikhail, Park, David C.
Publicado no Leukemia (2018)

Brief report: Screening for germline EGFR T790M mutations through lung cancer genotyping

Por Oxnard, Geoffrey R., Miller, Vincent A., Robson, Mark E., Azzoli, Christopher G., Pao, William, Ladanyi, Marc, Arcila, Maria E.
Publicado em 2012

Clinical and in vivo Evidence that EGFR S768I Mutant Lung Adenocarcinomas Are Sensitive to Erlotinib

Por Hellmann, Matthew D., Reva, Boris, Yu, Helena, Rusch, Valerie W, Rizvi, Naiyer A, Kris, Mark G, Arcila, Maria E
Publicado no J Thorac Oncol (2014)

Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain

Por Yu, Helena A., Tian, Shaozhou K., Drilon, Alexander E., Borsu, Laetitia, Riely, Gregory J., Arcila, Maria E., Ladanyi, Marc
Publicado no JAMA Oncol (2015)

Clinical Application of Picodroplet Digital PCR Technology for Rapid Detection of EGFR T790M in Next-Generation Sequencing Libraries and DNA from Limited Tumor Samples

Por Borsu, Laetitia, Intrieri, Julie, Thampi, Linta, Yu, Helena, Riely, Gregory, Nafa, Khedoudja, Chandramohan, Raghu, Ladanyi, Marc, Arcila, Maria E.
Publicado no J Mol Diagn (2016)

Novel Modification of HistoGel-Based Cell Block Preparation Method: Improved Sufficiency for Molecular Studies

Por Rekhtman, Natasha, Buonocore, Darren J., Rudomina, Dorota, Friedlander, Maria, Dsouza, Crisbane, Aggarwal, Gitika, Arcila, Maria, Edelweiss, Marcia, Lin, Oscar
Publicado no Arch Pathol Lab Med (2017)

Germline EGFR T790M mutation found in multiple members of a familial cohort

Por Yu, Helena A., Arcila, Maria E., Harlan, Megan, Stadler, Zsofia, Ladanyi, Marc, Berger, Michael F., Robson, Mark, Riely, Gregory J.
Publicado no J Thorac Oncol (2014)

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials

Por Hyman, David M., Solit, David B., Arcila, Maria E., Cheng, Donavan, Sabbatini, Paul, Baselga, Jose, Berger, Michael F., Ladanyi, Marc
Publicado no Drug Discov Today (2015)

AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants

Por Hechtman, Jaclyn F., Sadowska, Justyna, Huse, Jason T., Borsu, Laetitia, Yaeger, Rona, Shia, Jinru, Vakiani, Efsevia, Ladanyi, Marc, Arcila, Maria E.
Publicado no Mol Cancer Res (2015)

NF1 Mutations are Common in Desmoplastic Melanoma

Por Wiesner, Thomas, Kiuru, Maija, Scott, Sasinya N., Arcila, Maria, Halpern, Allan C., Hollmann, Travis, Berger, Michael F., Busam, Klaus J.
Publicado no Am J Surg Pathol (2015)

KRAS Mutation is a Significant Prognostic Factor in Early Stage Lung Adenocarcinoma

Por Kadota, Kyuichi, Sima, Camelia S., Arcila, Maria E., Hedvat, Cyrus, Kris, Mark G., Jones, David R., Adusumilli, Prasad S., Travis, William D.
Publicado no Am J Surg Pathol (2016)